Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
Decision snapshot: BXP stock price vs CSGP: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at CSGP's multiple
Needs CSGP P/E.
Implied fair value · at BXP's multiple
Needs BXP P/E.
Price unavailable
Metric by metric
Where each company leads, and how wide the gap is.
Growth lag
Reported gross margin
Operating income + D&A
Lower is better
Not comparable
Lower leverage
Statements
Annual statements in reported currencies, with calculations and source evidence.
Values retain reported currencies and share bases. Select a figure to inspect its period, calculation and filing inputs. Differences require compatible units and periods.
Explore enterprise value and market valuation multiples in the valuation sections.
Trendline
16 period-end years of reported revenue, earnings, and margins. Periods and currencies are shown with the data.
Price framework
USD market cap plus reported borrowing debt, less cash and equivalents. This EV proxy excludes investments, preferred stock and noncontrolling-interest adjustments.
Complete market value, debt and cash evidence is required for enterprise value.
Complete market value, debt and cash evidence is required for enterprise value.
Price framework
The same filing-backed model used on each company's valuation page, with company-specific inputs and calculated scenarios.
BXP, INC. · implied price per share
Five annual free-cash-flow observations are required for the filing-backed baseline.
CoStar Group, Inc. · implied price per share
Debt and bridge-cash inputs are required to translate enterprise value into equity value.
Balance sheet health
Inspect reported liquidity and leverage alongside historical financial-health checks.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
Cash excludes investments. EBITDA is an operating-income-plus-D&A proxy. Missing borrowing categories remain unavailable; select a value to inspect its inputs.
LLM-powered synthesis
An explanation of the financial evidence. Check its snapshot date against the figures above.
This explanation uses an earlier data snapshot or evidence version. Review its generation date and the current figures, or refresh after signing in.
If you believe CSGP's extremely high P/E (1880.0x) and premium P/S (4.9x) are sustainable because its faster revenue growth (18.7%) will soon convert into durable earnings, then avoid initiating a BXP position because BXP's lower-growth profile (2.2%) may prevent re-rating; otherwise, buy BXP because it trades near its historical band ($49.53-$60.53) while offering materially stronger profitability (Net Income $276.8M, ROIC 13.1%) and a far lower P/E (31.6x).
There is a very large theoretical pricing gap driven by applying CSGP multiples to BXP: an implied price of $3,271.20 (5844.4% upside) is driven by CSGP's extreme P/E. The lower end of CSGP-implied range ($61.45) is only modestly above BXP's current price and BXP sits near the middle of its historical band, suggesting the extreme upper bound is not a practical valuation BXP.
Supporting Metrics
